Glycine transporter 1 inhibitor, bitopertin, changes excitatory and inhibitory network connectivity in mouse medial prefrontal cortex
Authors:
- Martin GrafMGMartin Graf
- Marion PonserreMPMarion Ponserre
- Sadra SadehSSSadra Sadeh
- Jamie RobinsonJRJamie Robinson
- Madeleine CoyMCMadeleine Coy
- Madeleine HungerMHMadeleine Hunger
- Anne LienALAnne Lien
- Daniel UrsuDUDaniel Ursu
- Azar OmraniAOAzar Omrani
- Lorenza MagnoLMLorenza Magno
- Bastian HengererBHBastian Hengerer
- Holger RosenbrockHRHolger Rosenbrock
- 10 September 2026
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 301
Abstract
No abstract availableFunding Information
- Wellcome Trust (225412/Z/22/Z)
- Boehringer Ingelheim
This publication has 49 references indexed in Scilit:
- Mapping the functional connectome of the claustrum: Noise filtering via local inhibitory circuitsCell Reports, 2026
- Alterations in Prefrontal Cortical Somatostatin Neurons in Schizophrenia: Evidence for Weaker Inhibition of Pyramidal Neuron DendritesBiological Psychiatry, 2025
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophreniaBiochemical Pharmacology, 2024
- Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in SchizophreniaJAMA Psychiatry, 2023
- Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2023
- Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodentsEuropean Journal of Pharmacology, 2022
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of SchizophreniaJAMA Psychiatry, 2014
- Pyramidal Neurons in Prefrontal Cortex Receive Subtype-Specific Forms of Excitation and InhibitionNeuron, 2014
- Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: Evidence from genetically modified mouse models and pharmacological inhibitionBiochemical Pharmacology, 2011
- Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with SchizophreniaBiological Psychiatry, 2009